Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

2.95
Delayed Data
As of Aug 18
 -0.05 / -1.67%
Today’s Change
1.95
Today|||52-Week Range
4.08
+13.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$136.1M

Company Description

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. Its product candidates is comprised of DSUVIA, and ZALVISO, which both contains sufentanil as a therapeutic ingredient. The company was founded by Thomas A. Schreck and Pamela P. Palmer on July 13, 2005 and is headquartered in Redwood City, CA.

Contact Information

AcelRx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City California 94063
P:(650) 216-3500
Investor Relations:

Employees

Shareholders

Mutual fund holders5.81%
Individual stakeholders24.56%
Other institutional18.20%

Top Executives

Vincent J. AngottiChief Executive Officer
Raffi AsadorianChief Financial Officer
Pamela Pierce PalmerDirector & Chief Medical Officer
Badri N. DasuChief Engineering Officer
Jane Wright-MitchellSecretary, Chief Legal & Compliance Officer